Cargando…

Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma

Background: FGFR inhibition has been proposed as treatment for dedifferentiated liposarcoma (DDLPS) with amplified FRS2, but we previously only demonstrated transient cytostatic effects when treating FRS2-amplified DDLPS cells with NVP-BGJ398. Methods: Effects of the more potent FGFR inhibitor LY287...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanes, Robert, Munthe, Else, Grad, Iwona, Han, Jianhua, Karlsen, Ida, McCormack, Emmet, Meza-Zepeda, Leonardo A., Stratford, Eva Wessel, Myklebost, Ola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406403/ https://www.ncbi.nlm.nih.gov/pubmed/30795553 http://dx.doi.org/10.3390/cells8020189

Ejemplares similares

Crystal Structure of the FGFR4/LY2874455 Complex Reveals Insights into the Pan-FGFR Selectivity of LY2874455
por: Wu, Daichao, et al.
Publicado: (2016)

Radiosensitization by the Selective Pan-FGFR Inhibitor LY2874455
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2022)

Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma
por: Hanes, Robert, et al.
Publicado: (2016)

Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion
por: Kim, Sun Young, et al.
Publicado: (2017)

Molecular mechanisms of the anti-cancer drug, LY2874455, in overcoming the FGFR4 mutation-based resistance
por: Dehghanian, Fariba, et al.
Publicado: (2021)

Characterization of Liposarcoma Cell Lines for Preclinical and Biological Studies
por: Stratford, Eva W., et al.
Publicado: (2012)

Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening
por: Grad, Iwona, et al.
Publicado: (2021)

Preclinical Evaluation of Vemurafenib as Therapy for BRAF(V600E) Mutated Sarcomas
por: Gouravan, Sarina, et al.
Publicado: (2018)

Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA
por: Serguienko, Anastassia, et al.
Publicado: (2014)

Liposarcoma cells with aldefluor and CD133 activity have a cancer stem cell potential
por: Stratford, Eva W, et al.
Publicado: (2011)

LY2874455 and Abemaciclib Reverse FGF3/4/19/CCND1 Amplification Mediated Gefitinib Resistance in NSCLC
por: Liu, Dongcheng, et al.
Publicado: (2022)

Accurate 3-gene-signature for early diagnosis of liposarcoma progression
por: Serguienko, Anastassia, et al.
Publicado: (2020)

The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines
por: Wessel Stratford, Eva, et al.
Publicado: (2014)

Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b
por: Engkvist, M. E., et al.
Publicado: (2017)

Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes
por: Lauvrak, S U, et al.
Publicado: (2013)

Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data
por: Jing, Wenyi, et al.
Publicado: (2021)

FRS2-independent GRB2 interaction with FGFR2 is not required for embryonic development
por: Clark, James F, et al.
Publicado: (2023)

FRS2-independent GRB2 interaction with FGFR2 is not required for embryonic development
por: Clark, James F., et al.
Publicado: (2023)

FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro
por: Künstlinger, Helen, et al.
Publicado: (2015)

The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
por: Ho, Thai H, et al.
Publicado: (2015)

Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene
por: Barøy, Tale, et al.
Publicado: (2016)

miR-486-5p expression is regulated by DNA methylation in osteosarcoma
por: Namløs, Heidi M., et al.
Publicado: (2022)

Role and expression of FRS2 and FRS3 in prostate cancer
por: Valencia, Tania, et al.
Publicado: (2011)

Genomic landscape of liposarcoma
por: Kanojia, Deepika, et al.
Publicado: (2015)

FGFR1-Frs2/3 Signalling Maintains Sensory Progenitors during Inner Ear Hair Cell Formation
por: Ono, Kazuya, et al.
Publicado: (2014)

Epigenetic Regulation and Functional Characterization of MicroRNA-142 in Mesenchymal Cells
por: Skårn, Magne, et al.
Publicado: (2013)

FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer
por: Yang, Ying, et al.
Publicado: (2020)

The Super-FRS Project at GSI
por: Geissel, H, et al.
Publicado: (2002)

George Harley, F.R.S.
Publicado: (1899)

The transcriptional repressor complex FRS7-FRS12 regulates flowering time and growth in Arabidopsis
por: Ritter, Andrés, et al.
Publicado: (2017)

Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting
por: Dadone-Montaudié, Bérengère, et al.
Publicado: (2020)

HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo
por: Safavi, Setareh, et al.
Publicado: (2015)

FGFR1 is amplified during the progression of in situ to invasive breast carcinoma
por: Jang, Min Hye, et al.
Publicado: (2012)

FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
por: Yuan, Hong, et al.
Publicado: (2017)

Experiments with relativistic exotic nuclei at the FRS
por: Geissel, H
Publicado: (1994)

Targets for the proposed super-FRS at GSI
por: Sümmerer, K
Publicado: (2003)

Benjamin Moore FRS (1867–1922)
por: Agnew, Robin
Publicado: (2013)

The Late Edward Stanley, F.R.S.
Publicado: (1862)

Mr. Jonathan Hutchinson, F.R.S.
Publicado: (1903)

The Works of William Hewson, F.R.S.
Publicado: (1847)

Cannot write session to /tmp/vufind_sessions/sess_hche83r1ps275dkljh4q9ul17e